MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections.
about
Kirby-Bauer disc approximation to detect inducible third-generation cephalosporin resistance in EnterobacteriaceaeCefepimeIntegration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa.Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health regionAppropriate and timely empirical antimicrobial treatment of icu infections--a role for carbapenems.Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan.Intra-abdominal infections: etiology, epidemiology, microbiological diagnosis and antibiotic resistance.CANCER resistance surveillance program: initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance.Pharmacokinetics of meropenem 0.5 and 2 g every 8 hours as a 3-hour infusion.Quinolone-resistant clinical strains of Pseudomonas aeruginosa isolated from University Hospital in Tunisia.
P2860
Q24794095-06673610-62F4-43BD-B02B-8EAC9B73EB06Q29040262-8C342ADA-7BC3-41C8-A92F-4E9251EB3B16Q30775587-2BCCE100-1526-45EC-B24F-969757666E78Q33856392-D6FB335E-7B53-4A93-8FA4-DED3112F9C73Q36219506-F593678D-9703-45C2-8D2A-045FAA490EFAQ36839703-A75FF65B-9808-483D-9013-22DC266C8904Q37420672-971C19D3-3BD0-48F1-9199-1E4D2E8D5DDEQ37557841-E6135C0E-ABA9-42FE-BC92-88DF29847427Q44263661-5749F6D1-CF7A-421B-ABA9-F3832FB54153Q44551301-C7B50A91-9F51-4612-AF79-DA315075C2F2Q53716911-F69DF40C-D1CA-4DD5-A893-0DA4FD1E10F3
P2860
MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
MYSTIC (Meropenem Yearly Susce ...... eatment of serious infections.
@en
MYSTIC
@nl
type
label
MYSTIC (Meropenem Yearly Susce ...... eatment of serious infections.
@en
MYSTIC
@nl
prefLabel
MYSTIC (Meropenem Yearly Susce ...... eatment of serious infections.
@en
MYSTIC
@nl
P356
P1476
MYSTIC (Meropenem Yearly Susce ...... eatment of serious infections.
@en
P2093
P356
10.1093/JAC/46.SUPPL_2.25
P407
P478
46 Suppl B
P577
2000-08-01T00:00:00Z